Thomas Lu
👤 PersonAppearances Over Time
Podcast Appearances
Two judges blocked that grant freeze, but on Monday the 10th, one of them ruled that some of that money still hadn't been released. The order had been ignored. And researchers, like one clinical psychologist we spoke to, they're worried about the future of their funding.
Even after the judge's order, agencies like the NSF specifically said grants would be awarded, quote, in the context of recent executive orders, which has a lot of people thinking about that list of forbidden terms, especially when it comes to research on things like MPOCs or reproductive health. Like one researcher said in an interview with Katie Couric.
Even after the judge's order, agencies like the NSF specifically said grants would be awarded, quote, in the context of recent executive orders, which has a lot of people thinking about that list of forbidden terms, especially when it comes to research on things like MPOCs or reproductive health. Like one researcher said in an interview with Katie Couric.
Even after the judge's order, agencies like the NSF specifically said grants would be awarded, quote, in the context of recent executive orders, which has a lot of people thinking about that list of forbidden terms, especially when it comes to research on things like MPOCs or reproductive health. Like one researcher said in an interview with Katie Couric.
Meanwhile, the Trump administration has been telling researchers at the CDC what to study and what not to study. They've withheld research on bird flu and told scientists to do more research on the health effects of wildfires, at the same time that the president has been criticizing California's response to those wildfires.
Meanwhile, the Trump administration has been telling researchers at the CDC what to study and what not to study. They've withheld research on bird flu and told scientists to do more research on the health effects of wildfires, at the same time that the president has been criticizing California's response to those wildfires.
Meanwhile, the Trump administration has been telling researchers at the CDC what to study and what not to study. They've withheld research on bird flu and told scientists to do more research on the health effects of wildfires, at the same time that the president has been criticizing California's response to those wildfires.
And then finally, at the end of last week, the NIH announced its own major funding cut.
And then finally, at the end of last week, the NIH announced its own major funding cut.
And then finally, at the end of last week, the NIH announced its own major funding cut.
Like lots of things these days, that decision was temporarily blocked by a judge. But scientists, doctors, university administrators, they're confused. They don't know what kind of research is permitted. They're not sure how they're allowed to communicate. They have no idea if they're going to get paid.
Like lots of things these days, that decision was temporarily blocked by a judge. But scientists, doctors, university administrators, they're confused. They don't know what kind of research is permitted. They're not sure how they're allowed to communicate. They have no idea if they're going to get paid.
Like lots of things these days, that decision was temporarily blocked by a judge. But scientists, doctors, university administrators, they're confused. They don't know what kind of research is permitted. They're not sure how they're allowed to communicate. They have no idea if they're going to get paid.
That's Derek Lowe. He's been working in pharmaceutical research for over 30 years, and he writes In the Pipeline, which is one of the most influential and longest-running science blogs out there. Derek's got kind of an insider-outsider perspective on all of this.
That's Derek Lowe. He's been working in pharmaceutical research for over 30 years, and he writes In the Pipeline, which is one of the most influential and longest-running science blogs out there. Derek's got kind of an insider-outsider perspective on all of this.
That's Derek Lowe. He's been working in pharmaceutical research for over 30 years, and he writes In the Pipeline, which is one of the most influential and longest-running science blogs out there. Derek's got kind of an insider-outsider perspective on all of this.
He's super well-connected to researchers on the inside of the national science agencies, but because his research isn't funded by the NIH or the NSF, He's not financially tied to what happens. He doesn't have government grants that are going to get canceled here. And as someone who works on the applied side of science, he knows what can happen when basic research gets disrupted.
He's super well-connected to researchers on the inside of the national science agencies, but because his research isn't funded by the NIH or the NSF, He's not financially tied to what happens. He doesn't have government grants that are going to get canceled here. And as someone who works on the applied side of science, he knows what can happen when basic research gets disrupted.
He's super well-connected to researchers on the inside of the national science agencies, but because his research isn't funded by the NIH or the NSF, He's not financially tied to what happens. He doesn't have government grants that are going to get canceled here. And as someone who works on the applied side of science, he knows what can happen when basic research gets disrupted.
So he's been following the disruptions over the last couple weeks extremely closely.